MAGEA3 抗体
(Melanoma Antigen Family A, 3 (MAGEA3))
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. [provided by RefSeq, Jul 2008].
recommended
recommended
recommended
MAGEA3 抗体 by 适用
Find MAGEA3 抗体 for a variety of species such as anti-Human MAGEA3, anti-Mouse MAGEA3, anti-Rat MAGEA3. The species listed below are among those available. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 应用范围
Find MAGEA3 抗体 validated for a specific application such as WB, ELISA, IHC, FACS. Some of the available applications are listed below. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 抗体来源
Find MAGEA3 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 抗原表位
Find MAGEA3 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 克隆形成能力
Find available monoclonal or polyclonal MAGEA3 抗体. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 克隆
Find MAGEA3 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
MAGEA3 抗体 by 标记
Find MAGEA3 抗体 with a specific conjugate such as FITC, Biotin, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular MAGEA3 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (1)
- (3)
Cat. No.
ABIN561731
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (3)
Cat. No.
ABIN7159260
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (3)
Cat. No.
ABIN7238165
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, FACS, IHC (p)
Validations
- (3)
- (3)
Cat. No.
ABIN390107
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (2)
Cat. No.
ABIN561730
Quantity
50 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IP
Validations
- (2)
Cat. No.
ABIN517687
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF
Validations
- (2)
Cat. No.
ABIN948098
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IHC (p)
Validations
- (2)
Cat. No.
ABIN604749
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IHC (p)
Validations
- (2)
Cat. No.
ABIN1499254
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN1327686
Quantity
50 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN1499259
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
ELISA
Validations
Cat. No.
ABIN7159263
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA
Validations
Cat. No.
ABIN7159261
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN6389512
Quantity
100 μL
Datasheet
Datasheet
Latest Publications for our MAGEA3 抗体
: "Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial ..." in: Urologia internationalis, Vol. 102, Issue 1, pp. 77-82, (2019) (PubMed).: "MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2." in: Journal of Cancer, Vol. 7, Issue 6, pp. 656-63, (2016) (PubMed).
: "Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient." in: Molecular vision, Vol. 20, pp. 956-69, (2014) (PubMed).
: "Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma." in: International journal of clinical and experimental pathology, Vol. 7, Issue 7, pp. 4112-9, (2014) (PubMed).
: "?-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial." in: BMC cancer, Vol. 12, pp. 623, (2013) (PubMed).
: "MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma." in: Leukemia, Vol. 22, Issue 8, pp. 1646-8, (2008) (PubMed).
: "The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 16, pp. 4713-20, (2007) (PubMed).
: "MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis." in: Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 30, Issue 7, pp. 675-83, (2007) (PubMed).
Aliases for MAGEA3 抗体
MAGE family member A3 (MAGEA3) 抗体melanoma antigen, family A, 3 (Magea3) 抗体
melanoma antigen family A, 3 (MAGEA3) 抗体
CT1.3 抗体
HIP8 抗体
HYPD 抗体
Mage-a3 抗体
MAGE3 抗体
MAGEA3 抗体
MAGEA6 抗体
您还需要查找其他产品吗？
You are here:
